Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 8, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.8K

Retroperitoneal lymph node dissection: an update in testicular malignancies.

K Yadav1

  • 1Max Institute of Cancer Care, Maxhealthcare, Gurgaon, Haryana, India. Kaushalyadavoo7@yahoo.com.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|February 3, 2017
PubMed
Summary

Retroperitoneal lymph node dissection (RPLND) improves testicular cancer staging and treatment. This procedure offers curative potential for low-volume disease and guides adjuvant therapy, minimizing radiation exposure from follow-up imaging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radical Neck Dissection Following Internal Carotid Artery Endovascular Stenting: Case Report and Review of Literature.

Indian journal of surgical oncology·2024
Same author

Latissimus Dorsi Muscle Onlay Flap Post-esophagectomy Leakage with Mediastinitis and Failed Stenting.

Indian journal of surgical oncology·2020
Same author

Portocaval Paraganglioma : First Case Report and Review of Literature.

Journal of gastrointestinal cancer·2017
See all related articles

Area of Science:

  • Urologic Oncology
  • Surgical Oncology
  • Medical Imaging

Background:

  • Testicular cancer management has advanced significantly, driven by efforts to enhance oncologic outcomes and reduce patient morbidity.
  • Current imaging techniques for testicular cancer have limitations, leading to understaging of Stage I disease (30%) and overstaging of Stage II disease (25-30%).
  • Retroperitoneal lymph node dissection (RPLND) has emerged as a critical tool in the management of testicular malignancy.

Purpose of the Study:

  • To refine the challenging management of testicular cancer through evidence-based review of retroperitoneal lymph node dissection (RPLND).
  • To highlight the potential of RPLND in improving staging accuracy, prognostication, and therapeutic strategies for testicular cancer.
  • To address persistent controversies surrounding RPLND despite its long evolutionary period.
Keywords:
Germ cell tumors of testisRetroperitoneal lymph node dissection (RPLND)SeminomaTesticular malignancies

More Related Videos

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
06:46

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection

Published on: January 9, 2026

232
Murine Bilateral Renal Lymphadenectomy
06:20

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

127

Related Experiment Videos

Last Updated: Mar 8, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.8K
Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
06:46

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection

Published on: January 9, 2026

232
Murine Bilateral Renal Lymphadenectomy
06:20

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

127

Main Methods:

  • Review of scientific literature and evidence pertaining to retroperitoneal lymph node dissection (RPLND) in testicular cancer management.
  • Analysis of RPLND's role in overcoming limitations of current diagnostic imaging modalities.
  • Evaluation of RPLND's efficacy in staging, prognostication, and treatment, particularly for low-volume disease and post-chemotherapy residual disease.

Main Results:

  • RPLND offers improved accuracy in staging testicular cancer compared to imaging, addressing understaging and overstaging issues.
  • For low-volume testicular cancer, RPLND is curative in up to 90% of cases without adjuvant therapy.
  • RPLND plays a crucial role in managing post-chemotherapy residual disease and guiding adjuvant therapy decisions.
  • The risk of recurrence after RPLND is low (1%), potentially allowing for limited follow-up imaging and reduced radiation exposure.

Conclusions:

  • Retroperitoneal lymph node dissection (RPLND) is a vital procedure for staging, prognostication, and therapy in testicular cancer management.
  • RPLND provides crucial information about disease nature, aids in guiding adjuvant therapy, and offers a curative option for specific patient groups.
  • Further refinement of RPLND protocols based on available evidence is necessary to address ongoing controversies and optimize patient outcomes.